OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
46
Frequently Asked Questions
What is Market Cap of OnKure Therapeutics Inc. - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. OnKure Therapeutics Inc. - Ordinary Shares - Class A market cap is $35.31M.
What is the 52-week high for OnKure Therapeutics Inc. - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. OnKure Therapeutics Inc. - Ordinary Shares - Class A 52 week high is $20.00 as of September 24, 2025.
What is the 52-week low for OnKure Therapeutics Inc. - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OnKure Therapeutics Inc. - Ordinary Shares - Class A 52 week low is $1.70 as of September 24, 2025.
What is OnKure Therapeutics Inc. - Ordinary Shares - Class A stock price today?
OnKure Therapeutics Inc. - Ordinary Shares - Class A stock price today is $2.53.
What was OnKure Therapeutics Inc. - Ordinary Shares - Class A stock price yesterday?
OnKure Therapeutics Inc. - Ordinary Shares - Class A stock price yesterday was $2.61.
What is the PE ratio of OnKure Therapeutics Inc. - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. OnKure Therapeutics Inc. - Ordinary Shares - Class A’s P/E ratio is -0.49.
What is the Price-to-Book ratio of OnKure Therapeutics Inc. - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. OnKure Therapeutics Inc. - Ordinary Shares - Class A P/B ratio is 0.4518.
What is the 50-day moving average of OnKure Therapeutics Inc. - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. OnKure Therapeutics Inc. - Ordinary Shares - Class A 50-day moving average is $2.47.
How many employess does OnKure Therapeutics Inc. - Ordinary Shares - Class A has?
OnKure Therapeutics Inc. - Ordinary Shares - Class A has 46 employees.
